Yuvo
Yuvo is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Yuvo.
Yuvo is a company.
Key people at Yuvo.
Yuvo Health is a New York City-based technology-enabled platform that provides administrative, operational, and managed-care solutions to Federally Qualified Health Centers (FQHCs), enabling them to participate in value-based care (VBC) without financial risk.[1][2][3][5] It serves community health centers (CHCs) by negotiating lucrative VBC contracts across all lines of business, managing risk, delivering upfront monthly payments for cash flow stability, and unifying performance metrics to maximize revenue from whole-person care.[6][7] The company solves the operational burden and revenue limitations that prevent FQHCs—the primary care access point for millions of underserved Americans—from scaling VBC participation, allowing them to focus on compassionate community care.[1][3] Yuvo has shown strong growth momentum, raising $7.3M in seed funding (Jan 2022), $20.2M in Series A (Jun 2023), and $8.17M in Series A-II (Dec 2024), totaling $37.67M, while expanding from New York to Ohio and beyond.[1][2][4][5]
Yuvo Health launched in early 2021, founded by a fully BIPOC team—including CEO and co-founder Cesar Herrera—who drew from personal experiences with quality care in underserved communities to address gaps in primary care access.[1][2][3] The idea emerged from recognizing FQHCs' potential to lead in VBC but their struggles with administrative hurdles, investment needs, and risk; the founders built an ecosystem partner to provide scalable infrastructure, payment systems, and partnerships.[1][3] Early traction included a $7.3M seed round in January 2022 led by AlleyCorp (with AV8 Ventures, New York Ventures, and others), enabling entry into Downstate New York, team expansion into quality analytics, care coordination, and risk adjustment, plus the first in-person offsite to codify mission and values.[2][5] Pivotal moments: oversubscribed $20.2M Series A in June 2023 (led by Mastry Ventures), fueling multi-market scaling.[1][3][5]
Yuvo rides the shift from fee-for-service to value-based care, a trend driven by policy changes emphasizing outcomes, cost reduction, and health equity in U.S. healthcare.[1][3][6] Timing aligns with FQHCs' role as the sole primary care for millions of underserved, amid rising Medicaid VBC mandates and payer demands for whole-person care, where CHCs excel but lack infrastructure.[3][6] Market forces favoring Yuvo include FQHC funding pressures, VBC revenue opportunities (beyond Medicaid), and investor interest in health tech equity plays, as seen in backing from diversity-focused funds like Mastry Ventures.[1][3] It influences the ecosystem by empowering CHCs with "a meaningful seat at the VBC table," bending risk curves, stabilizing cash flows, and scaling compassionate care models that reduce costs and improve outcomes.[1][6]
Yuvo is poised for accelerated national expansion post-2024 Series A-II funding, targeting more markets with refined revenue models and deeper VBC penetration across payer lines.[1][4][6] Trends like AI-driven quality analytics, further Medicaid reforms, and payer consolidation will amplify its platform's edge in unifying metrics and de-risking participation. Its influence may evolve into a dominant FQHC infrastructure leader, potentially attracting Series B interest and partnerships with major health plans, solidifying BIPOC-led innovation in health equity. This builds on its mission to unlock sustainable revenue for CHCs, ensuring underserved communities receive the compassionate care they deserve.[1][5][6]
Key people at Yuvo.
